- Filed
- May 5, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 1, 2026 | 81M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 80.32M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 79.53M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2024 | 80.32M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $7.51M |
| Capex | Q1 2026 · Mar 31, 2025 | $7.4M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $12.67M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $43.18M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $88.27M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $95.7M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $359.21M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $361.86M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $678.53M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $685.34M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $634.22M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $635.22M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $1.19B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $1.2B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.01 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.14 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2024 | −$0.01 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.01 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.14 |
| Eps Basic restated | Q1 2026 · Mar 31, 2024 | −$0.01 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $55.84M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $50.29M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $50.78M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $48.86M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$1.32M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$11.27M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $6.38M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$3.97M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $112.99M |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $95.18M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $173.1M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $152.57M |
| Revenue | Q1 2026 · Mar 31, 2026 | $286.09M |
| Revenue | Q1 2026 · Mar 31, 2025 | $247.74M |